alekhkhanna
Innovator
Well, the challenge is if the drug doesn't work, any amount of money spent on buying it money down the drain, be it 1 rupee or 100 rupees. As it is, the USFDA has a ****ing 45% range for generics to work with (80% to 125% of the original molecule), and that itself can create issues.As someone who interned at some of these places I can vouch for some of the issues in the book too. During my interns we have to reverse engineer a chemical patent and even after multiple centrifuge runs nothing happened. The company man directing our internship came and changed the numbers using whitener and simply writing over it.
Though I felt the bashing has to be measured against what is the cause behind the rise of generics. R&D costs are high and because US has insurance paid programs people get away with high price. But, there are others who need lower price even if the price is too good to be true, people still want to believe it.
Now we are dealing with either non working API or worse, illegal substitutes which can kill individuals. Not acceptable for any cost, not even for free.